Silicon valley investor takes control of cdc as kennedy's right-hand man
Aug. 29, 2025: Thiel-linked investor named acting CDC head
Jim O'Neill, a longtime associate of Peter Thiel and a former executive at Thiel-affiliated firms, became acting CDC director on Aug. 28, 2025. He took the post after Susan Monarez was fired on Aug. 27, 2025, by Kennedy amid reported disputes over vaccine policy. O'Neill has advocated loosening some FDA and diagnostic rules and speeding approvals for certain drugs and tests. He co-founded the Thiel Fellowship, which pays college dropouts to build startups. Reporting links him to investment roles tied to Thiel-affiliated funds, but earlier claims about a specific $1.2 billion fund and a single fellowship dollar figure are unverified.
Why this matters
<ul> <li><strong>🔬 Biotech deregulation advocate now controls federal drug oversight</strong>: O'Neill spent years pushing to speed up FDA approvals and eliminate safety barriers while investing in companies that profit from relaxed regulations. This creates direct financial conflicts of interest.</li> <li><strong>💰 Silicon Valley network gains unprecedented health policy influence</strong>: The Thiel circle that created Palantir surveillance technology now controls CDC policy affecting 330 million Americans. Tech industry priorities replace public health expertise.</li> <li><strong>⚗️ CDC scientists abandon agency under corporate leadership</strong>: Career epidemiologists resigned warning that science should never be subject to political interference. Institutional knowledge disappears when corporate interests take command.</li> <li><strong>🏛️ Public health becomes venture capital investment opportunity</strong>: When biotech investors control health agencies, regulatory decisions benefit portfolio companies rather than population health. Scientific independence gets replaced by profit-driven policy making.</li> </ul>
Core Facts
Susan Monarez was removed as CDC director on Aug. 27, 2025. Reporters said she resisted vaccine-policy changes ordered by HHS Secretary Robert F. Kennedy Jr. Her departure came within weeks of her Senate confirmation.
HHS Deputy Secretary Jim O'Neill was named acting CDC director on Aug. 28, 2025. Kennedy tapped his deputy to lead the agency after Monarez's removal. O'Neill will serve temporarily while officials search for a permanent director.
O'Neill has a private-sector background in venture investing and has worked with funds linked to Peter Thiel. Those ties have prompted conflict-of-interest concerns among public-health experts and watchdogs. Critics say those connections raise questions about potential policy shifts that could benefit biotech investors.
Several senior CDC officials resigned or announced departures after Monarez's firing, including Chief Medical Officer Debra Houry on Aug. 28, 2025. Houry warned staff about rising misinformation and urged protection of scientific integrity in internal messages. Officials say the departures have disrupted agency operations during a sensitive leadership transition.
Key Actors
Jim O'Neill
HHS Deputy Secretary; Acting CDC Director (interim)
Named interim CDC director by HHS Secretary Robert F. Kennedy Jr. after Susan Monarez was removed. He is serving as the agency's top official while remaining HHS deputy.
Robert F. Kennedy Jr.
Secretary of Health and Human Services
Removed Susan Monarez as CDC director and appointed Jim O'Neill as interim CDC chief. He is leading the department's policy changes that prompted the leadership shift.
Susan Monarez
Former CDC Director
Was removed from her post in late Aug. 2025 after disputes with HHS leadership over policy direction. Her firing triggered the appointment of an interim director.
Peter Thiel
Investor and Technology Entrepreneur
Identified in reporting as a former business partner of Jim O'Neill. Coverage links him to investment networks interested in biotech policy and deregulation.
Dr. Debra Houry
Former CDC Chief Medical Officer
Reported to have resigned from CDC leadership following the agency's abrupt leadership changes. Her departure was listed among senior staff exits after Monarez's removal.
Actionable Insights
Call your U.S. representative via the House switchboard at 202-225-3121 and ask them to open oversight hearings into potential conflicts between Jim O'Neill's investments and CDC decisions.
Elected representatives can demand documents and hold public hearings. Ask your rep to press for public disclosures and ethics reviews of any ties that could affect CDC policy.
Call the Senate Health, Education, Labor and Pensions Committee at 202-224-5375 to request formal disclosure and records about O'Neill's ties to biotech and any influence on CDC policy.
The HELP Committee oversees public health policy and can compel documents and testimony. Ask the committee to hold public sessions and release relevant records.
Support independent watchdogs and public-health groups that track conflicts of interest and agency capture, such as Project On Government Oversight or Physicians for Social Responsibility.
Donate, volunteer, or share verified reporting to strengthen oversight and public pressure for transparency. Local journalists and editors respond when constituents push for coverage.
Test Your Knowledge
Ready to put your civic knowledge to the test? Take a quiz on this topic to see how well you understand the key concepts.
Start Quiz42 questions available